BIO Comments On Follow-On Biologics Will Include Manufacturing Anecdotes

FDA officials' questions to industry reps during public workshop focus on the level of studies that should be required for follow-on biologic applications, particularly in comparison to requirements for manufacturing process changes by innovators.